Kolexia
Auclin Edouard Oncologie médicale
Auclin Edouard
Oncologie médicale
Hôpital Européen Georges Pompidou
Paris, France
202 Activités
240 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Carcinomes Néphrocarcinome Tumeurs du côlon Métastase tumorale Tumeurs colorectales Adénocarcinome

Collaborateurs

Voir plus
Mezquita Perez Laura
Mezquita Perez Laura
Gustave-Roussy, Villejuif, France
Besse Benjamin
Besse Benjamin
Gustave-Roussy, Villejuif, France
Planchard David
Planchard David
Gustave-Roussy, Villejuif, France
Taieb Julien
Taieb Julien
Hôpital Européen Georges Pompidou, Paris, France

Industries

Voir plus
Amgen
12 collaboration(s)
Dernière en 2023
Janssen
3 collaboration(s)
Dernière en 2023
MSD
2 collaboration(s)
Dernière en 2023
Sanofi
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Nivolumab immunotherapy rechallenge for progressive laryngeal squamous cell carcinoma after failure of conventional treatment: A CARE case report.
European annals of otorhinolaryngology, head and neck diseases   27 février 2024
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
British journal of cancer   15 décembre 2023
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
Clinical lung cancer   22 novembre 2023
Spécificités cliniques et histologiques des récidives des carcinomes chromophobes après traitement chirurgical–étude UROCCR 136
117e congrès français d'urologie   01 novembre 2023
625P Efficacy and safety of the combination of encorafenib and cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: An AGEO real-world multicentre study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1450P Addition of bevacizumab to first-line chemoimmunotherapy in NSCLC with liver metastases
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
942P Response to salvage chemotherapy with paclitaxel +/- cetuximab after progression on immune checkpoint inhibitors in platinum-refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) patients (CeTax study)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study.
European journal of cancer (Oxford, England : 1990)   18 août 2023
Cemiplimab in association to chemotherapy in advanced non-small cell lung cancer.
Bulletin du cancer   25 juillet 2023
SO-17 A new risk classification integrating ctDNA, CEA, and pTN stage for DFS prognosis and predictive value for treatment duration in stage III colon cancer
Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023   01 juin 2023